IL17A and psoriasis: The aberrant type 1/17 immune responses represent a predominant mechanism in psoriasis due to the abundant release of type 1/17 cytokines such as IFN-γ, IL-17A, IL-23, and tumor necrosis factor (TNF)-α [68].